HUP9902421A2 - Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények - Google Patents

Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények

Info

Publication number
HUP9902421A2
HUP9902421A2 HU9902421A HUP9902421A HUP9902421A2 HU P9902421 A2 HUP9902421 A2 HU P9902421A2 HU 9902421 A HU9902421 A HU 9902421A HU P9902421 A HUP9902421 A HU P9902421A HU P9902421 A2 HUP9902421 A2 HU P9902421A2
Authority
HU
Hungary
Prior art keywords
optimising
medicament
enzyme
intestinal function
preparations
Prior art date
Application number
HU9902421A
Other languages
English (en)
Inventor
Michel Hooreman
Original Assignee
Michel Hooreman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michel Hooreman filed Critical Michel Hooreman
Publication of HUP9902421A2 publication Critical patent/HUP9902421A2/hu
Publication of HUP9902421A3 publication Critical patent/HUP9902421A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány gyógyászati készítményekre és élelmezési készítményekrevőnatkőzik, amelyek hatóanyagként egy enzimet, vagy a fenti enzimettartalmazó enzimkőmplexet - amelyet Streptőmices fradiae FR 2600340számú szabadalmi leírásban ismertetett körülmények közötttenyésztésével állítanak elő - tartalmaz fiziőlógiásan elfőgadható,inert hőrdőzóanyaggal vagy vivőanyaggal kőmbinációban, vagy elegyítve.A fenti készítmények degeneratív betegségek, különösen bélműködésizavarők megelőzésére vagy kezelésére alkalmazhatók. ŕ
HU9902421A 1996-04-05 1997-04-04 Medicament for optimising mucosal viscosity and stimulating intestinal function HUP9902421A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604310A FR2747045B1 (fr) 1996-04-05 1996-04-05 Nouveau medicament optimisant la viscosite des mucus et ameliorant le fonctionnement de l'intestin

Publications (2)

Publication Number Publication Date
HUP9902421A2 true HUP9902421A2 (hu) 1999-11-29
HUP9902421A3 HUP9902421A3 (en) 2001-05-28

Family

ID=9490963

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902421A HUP9902421A3 (en) 1996-04-05 1997-04-04 Medicament for optimising mucosal viscosity and stimulating intestinal function

Country Status (18)

Country Link
US (1) US6440413B1 (hu)
EP (1) EP0891189A1 (hu)
JP (1) JP4196225B2 (hu)
CN (1) CN1168499C (hu)
AP (1) AP1018A (hu)
AU (1) AU735340B2 (hu)
BR (1) BR9708506A (hu)
CA (1) CA2251009C (hu)
CZ (1) CZ298428B6 (hu)
FR (1) FR2747045B1 (hu)
HU (1) HUP9902421A3 (hu)
NO (1) NO324877B1 (hu)
NZ (1) NZ332107A (hu)
OA (1) OA10894A (hu)
PL (1) PL188157B1 (hu)
RU (1) RU2198673C2 (hu)
TR (1) TR199801976T2 (hu)
WO (1) WO1997037681A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041296B1 (en) * 1999-11-12 2006-05-09 The United States Of America As Represented By The Department Of Health And Human Services Methods of treating inflammatory bowel disease using cholera toxin B subunit
US20110158976A1 (en) * 2004-05-24 2011-06-30 Novozymes A/S Enzymes for pharmaceutical use
GB2430881B (en) * 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
BRPI0819662A2 (pt) 2007-12-04 2015-06-16 Novozymes As Protease, método para o tratamento de doenças, e, uso de uma protease
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
FR2998450A1 (fr) * 2012-11-26 2014-05-30 Dominique Hooreman Utilisation d'un complexe enzymatique dans l'alimentation des animaux d'elevage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1133579A (en) * 1966-03-09 1968-11-13 Shionogi & Co Process for preparing proteases and enzymatic composition prepared thereby
FR2600340A1 (fr) * 1986-06-20 1987-12-24 Hooremam Michel Procede de production d'un nouveau complexe proteolytique stimulant l'activite du pancreas et ses applications en zootechnie

Also Published As

Publication number Publication date
HUP9902421A3 (en) 2001-05-28
RU2198673C2 (ru) 2003-02-20
BR9708506A (pt) 1999-08-03
US6440413B1 (en) 2002-08-27
PL329161A1 (en) 1999-03-15
JP2000509025A (ja) 2000-07-18
TR199801976T2 (xx) 2000-10-23
JP4196225B2 (ja) 2008-12-17
PL188157B1 (pl) 2004-12-31
AP9801357A0 (en) 1998-12-31
CN1168499C (zh) 2004-09-29
NZ332107A (en) 2001-10-26
CN1221347A (zh) 1999-06-30
OA10894A (fr) 2003-02-21
CZ298428B6 (cs) 2007-10-03
NO984632D0 (no) 1998-10-02
AU735340B2 (en) 2001-07-05
EP0891189A1 (fr) 1999-01-20
AP1018A (en) 2001-10-15
FR2747045B1 (fr) 1998-06-26
FR2747045A1 (fr) 1997-10-10
NO324877B1 (no) 2007-12-27
CZ318598A3 (cs) 1999-05-12
CA2251009C (fr) 2013-07-02
CA2251009A1 (fr) 1997-10-16
AU2393897A (en) 1997-10-29
NO984632L (no) 1998-12-03
WO1997037681A1 (fr) 1997-10-16

Similar Documents

Publication Publication Date Title
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
ZA200107110B (en) Medicament for treating diabetes.
IL111734A0 (en) Compositions for the preparation of in vivo therapeutic products
IL110045A (en) Pharmaceutical compositions containing oligopeptides for combating AIDS and ARC and for immune stimulation and certain such novel oligopeptides
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
NO903542D0 (no) Frysetoerket blanding og fremgangsmaate for oral administrering av legemidler, naeringsmidler og biologisk aktive materialer.
IL112667A0 (en) 6-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
NO20001087D0 (no) Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer
HU9403343D0 (en) New pharmaceutical uses of krill enzymes
EP0797999A3 (en) Formulations of obesity protein
HUP0301349A2 (hu) IL-11-tartalmú készítmények
GR3006815T3 (hu)
WO1994008613A3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
HUP0105481A2 (hu) Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
HUP9902421A2 (hu) Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények
EP0347899A3 (en) Pharmaceutical compositions on egg shell basis and their preparation and use
AU1275401A (en) Fibrous-liponutritional complexes and compositions containing them
BG105275A (en) Tan-1057 derivatives
AU6122994A (en) Hiv protease inhibitors and their preparation
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
EP0385909A3 (en) A kit or composition for the prevention or treatment of HIV-1 infections

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees
NF4A Restoration of patent protection
FC4A Lapse of provisional application due to refusal